ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Toronto, ON

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Toronto, ON, CAN:

Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers

open label, multi-center, clinical study of Chimeric Antigen Receptor T Cells (CAR-T) targeting claudin18.2 in patients with advanced gastric, pancreatic...

Active, not recruiting
Gastric Cancer
Pancreatic Cancer
Biological: CT041

Phase 1, Phase 2

CARsgen Therapeutics

Toronto, Ontario, Canada and 15 other locations

to participants. Part C will use the information from Parts A and B to see if PF-08046049/SGN-BB228 is safe and if it works to treat solid tumor...

Enrolling
Non-small Cell Lung Cancer
Colorectal Neoplasms
Drug: PF-08046049

Phase 1

Seagen
Seagen

Toronto, Other, Canada and 21 other locations

Locations recently updated

This research is designed to determine if experimental treatment with PARP inhibitor, AZD5305, alone, or in combination with anti-cancer age....

Enrolling
Breast Cancer
Biliary Cancer
Drug: Camizestrant
Drug: T- Dxd

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Toronto, Ontario, Canada and 76 other locations

to assess the safety, tolerability, PK, PD, immunogenicity and anti-tumor activity of zenocutuzumab (MCLA-128) in patients with solid tumors...

Enrolling
Pancreatic Cancer Harboring NRG1 Fusion
NSCLC Harboring NRG1 Fusion
Drug: zenocutuzumab (MCLA-128)

Phase 2

Merus

Toronto, Ontario, Canada and 64 other locations

This phase II trial studies cediranib maleate in combination with olaparib in treating patients with solid tumors that have spread to other ...

Active, not recruiting
Stage IV Pancreatic Cancer AJCC v6 and v7
Pancreatic Ductal Adenocarcinoma
Other: 18F-Fluoromisonidazole
Drug: Cediranib Maleate

Phase 2

National Cancer Institute (NCI)
National Cancer Institute (NCI)

Toronto, Ontario, Canada and 15 other locations

of AZD0901 as monotherapy and in combination with anti-cancer agents in participants with locally advanced unresectable or metastatic solid ...

Enrolling
Gastroesophageal Junction Cancer
Gastric Cancer
Drug: l-leucovorin
Drug: Gemcitabine

Phase 2

AstraZeneca
AstraZeneca

Toronto, Ontario, Canada and 48 other locations

BOLD-100 is an intravenously administered sterile solution containing the ruthenium-based small molecule. BOLD-100 has been shown to preferentially d...

Enrolling
Gastric Cancers
Pancreatic Cancer
Drug: BOLD-100 in combination with FOLFOX Chemotherapy (Dose Expansion)
Drug: BOLD-100 in combination with FOLFOX Chemotherapy (Dose Escalation)

Phase 1, Phase 2

Bold Therapeutics

Toronto, Ontario, Canada and 13 other locations

biliary cancer that has spread to other organs. It is hoped that this new combination of drugs (nab-paclitaxel, gemcitabine, and cisplatin)...

Active, not recruiting
Unresectable Biliary Tract Cancer
Drug: nab-paclitaxel in combination with gemcitabine + cisplatin

Phase 2

AHS Cancer Control Alberta

Toronto, Ontario, Canada and 1 other location

This study is open to adults with advanced solid tumors whose previous cancer treatment was not successful. People can participate ...

Active, not recruiting
Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Carcinoma, Hepatocellular, Head and Neck Neoplasms, Gastrointestinal Neoplasms
Drug: BI 765049
Drug: ezabenlimab

Phase 1

Boehringer Ingelheim
Boehringer Ingelheim

Toronto, Canada and 12 other locations

patients with lymphoma, chronic lymphocytic leukemia, or solid tumors with liver dysfunction. Romidepsin may stop the growth of cancer...

Active, not recruiting
Recurrent Malignant Solid Neoplasm
Stage IV Prostate Cancer AJCC v7
Other: Pharmacological Study
Drug: Romidepsin

Phase 1

National Cancer Institute (NCI)
National Cancer Institute (NCI)

Toronto, Ontario, Canada and 11 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems